Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci185278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Shihui Shen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, Chi…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Proto-Oncogene Proteins p21(ras), Neoplasms, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.
- Joint Center for Translational Medicine, Shanghai Fifth People's Hospital, Fudan University and School of Life Science, East China Normal University, Shanghai, China.
- Organic Chemistry Group, College of Pharmacy, Naval Medical University, Shanghai, China.
- School of Energy and Environment, City University of Hong Kong, Hong Kong SAR, China.
- Health Science Center, East China Normal University, Shanghai, China.
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Shen, S., Zhang, Q., Wang, Y., Chen, H., Gong, S., Liu, Y., Gai, C., Chen, H., Zhu, E., Yang, B., Liu, L., Cao, S., Zhao, M., Ren, W., Li, M., Peng, Z., Zhang, L., Zhang, S., Shen, J., …, & Yang, H. (2025). Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models. Journal of Clinical Investigation. https://doi.org/10.1172/jci185278
Vancouver
Shen S, Zhang Q, Wang Y, Chen H, Gong S, Liu Y, et al. Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models. Journal of Clinical Investigation. 2025. doi:10.1172/jci185278
BibTeX
@article{Shen2025,
author = {Shen, Shihui and Zhang, Qiansen and Wang, Yuhan and Chen, Hui and Gong, Shuangming and Liu, Yun and Gai, Conghao and Chen, Hansen and Zhu, Enhao and Yang, Bo and Liu, Lin and Cao, Siyuan and Zhao, Mengting and Ren, Wenjie and Li, Mengjuan and Peng, Zhuoya and Zhang, Lu and Zhang, Shaoying and Shen, Juwen and Zhang, Bianhong and Lee, Patrick Kh and Li, Kun and Li, Lei and Yang, Huaiyu},
title = {Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci185278}
}
EUVIMED